Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01566396 · ClinicalTrials.gov registry record · NA
Evaluation of Safety and Efficacy of the 3F Applicator (A3F) for Treatment of Facial Wrinkles
A NA study, sponsored by Pollogen.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT01566396 is a NA study that has completed, run by Pollogen. The registered enrollment target is 32 participants.
The verdict
NCT01566396, a NA study, has completed, sponsored by Pollogen.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
The 3F Applicator (A3F) is indicated for use in dermatological procedures requiring ablation and resurfacing of the skin, and for the treatment of facial wrinkles. This study was designed in order to evaluate the safety and efficacy of the A3F for treatment of facial wrinkles.
Interventions
- DEVICE A3F
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2012-03 |
| Est. Completion | 2012-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01566396
The ClinicalTrials.gov registry entry for NCT01566396 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pollogen, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which A3F is the first listed.
NCT01566396 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01566396 about?
NCT01566396 is a clinical study titled "Evaluation of Safety and Efficacy of the 3F Applicator (A3F) for Treatment of Facial Wrinkles". The 3F Applicator (A3F) is indicated for use in dermatological procedures requiring ablation and resurfacing of the skin, and for the treatment of facial wrinkles. This study was designed in order to evaluate the safety and efficacy of the A3F for treatment of facial wrinkles.
What is the current status of trial NCT01566396?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2012-03. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01566396?
The interventions under investigation include: A3F (DEVICE).
Who is sponsoring clinical trial NCT01566396?
This trial is sponsored by Pollogen, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.